Nurse Practitioner Care Improves Renal Outcome in Patients with CKD
Author(s) -
Mieke J. Peeters,
Arjan D. van Zuilen,
Jan A.J.G. van den Brand,
Michiel L. Bots,
Marjolijn van Buren,
Marc A G J ten Dam,
Karin A. H. Kaasjager,
Gerry Ligtenberg,
Yvo W.J. Sijpkens,
Henk E. Sluiter,
Peter J.G. van de Ven,
Gerald Vervoort,
LouisJean Vleming,
Peter J. Blankestijn,
Jack F.M. Wetzels
Publication year - 2013
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2012121222
Subject(s) - medicine , renal function , hazard ratio , creatinine , randomized controlled trial , proteinuria , nephrology , clinical endpoint , acute kidney injury , confidence interval , kidney disease , incidence (geometry) , urology , nursing , intensive care medicine , kidney , physics , optics
Treatment goals for patients with CKD are often unrealized for many reasons, but support by nurse practitioners may improve risk factor levels in these patients. Here, we analyzed renal endpoints of the Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of Nurse Practitioners (MASTERPLAN) study after extended follow-up to determine whether strict implementation of current CKD guidelines through the aid of nurse practitioners improves renal outcome. In total, 788 patients with moderate to severe CKD were randomized to receive nurse practitioner support added to physician care (intervention group) or physician care alone (control group). Median follow-up was 5.7 years. Renal outcome was a secondary endpoint of the MASTERPLAN study. We used a composite renal endpoint of death, ESRD, and 50% increase in serum creatinine. Event rates were compared with adjustment for baseline serum creatinine concentration and changes in estimated GFR were determined. During the randomized phase, there were small but significant differences between the groups in BP, proteinuria, LDL cholesterol, and use of aspirin, statins, active vitamin D, and antihypertensive medications, in favor of the intervention group. The intervention reduced the incidence of the composite renal endpoint by 20% (hazard ratio, 0.80; 95% confidence interval, 0.66 to 0.98; P=0.03). In the intervention group, the decrease in estimated GFR was 0.45 ml/min per 1.73 m(2) per year less than in the control group (P=0.01). In conclusion, additional support by nurse practitioners attenuated the decline of kidney function and improved renal outcome in patients with CKD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom